Researchers plan to turn cancer cells into defectors, engineering them to kill the tumors from whence they came, and have tested the approach in mice.

Stem-cell–derived natural killer cells engineered in a similar way to CAR-T cells may pave the way to “off the shelf” cancer therapies that aren’t patient-specific.

Big data and empirical approaches to understanding diseases provide a limited picture of pathogenesis.

Machine-learning algorithms tuned to detecting cancer DNA in the blood could pave the way for personalized cancer care.

Two studies find the genome-editing technique works best when cells have a faulty DNA-damage response that’s frequently present in cancers.  

Reducing the evaluation to only direct contact, rather than including environmental exposures, could leave damaging substances on the market, critics say.

Researchers discover that a layer of human breast tissue is not one but two distinct cell types.  

Drugs approved to treat rheumatoid arthritis block cytokines, the molecules responsible for severe side effects from the immunotherapy, and reduce symptoms in mice.

The immunotherapy eliminated a woman’s metastatic lesions and kept her disease-free for two years.